Funktionsmenü_neu

Hauptnavigation

Current Investor News

Monday October 06, 2008

Novel approach for the treatment of pulmonary hypertension
Bayer Reports Progress in Clinical Program for Riociguat
Positive Phase II Findings Reported at European Respiratory Society Meeting / Phase III Studies to Begin in 2008

Wednesday October 01, 2008

Venous Blood Clot Prevention after Elective Hip or Knee Replacement Surgery:
Bayer's Novel Anticoagulant Xarelto® now also Approved in the EU
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care

Highlights

 

Investor Handout Meet Management in September 2008   PDF / 4.33 MB collectInvestor_Handout_Meet_Management_2008_Gesamt_final.pdf Investor Handout Meet Management Sept 2008

Bayer CropScience Annual Press Conference on September 4, 2008

On-Demand Recording: Q2 2008 Investor Conference Call   PDF / 248 KB collectQ2_2008_ConferenceCall_2008-07-30_Redecharts.pdf Redecharts Q2 2008 Investor Conference Call

Financial Report as of June 30, 2008   PDF / 1.04 MB collectQB_2008_2_e.pdf Financial Report as of June 30, 2008

Current Events
Tuesday, March 03, 2009
2008 Annual ReportRemind
Wednesday, October 29, 2008
Q3 2008 Investor Conference CallRemind
Latest Reports and Handout